3-Cyclopentylpropionyl chloride → N-(3-bromopyrazolo[1,5-a]pyrimidin-2-yl)-3-cyclopentylpropanamide
Reaction equation
[Br:1][C:2]1[C:3]([NH2:11])=[N:4][N:5]2[CH:10]=[CH:9][CH:8]=[N:7][C:6]=12.[CH:12]1([CH2:17][CH2:18][C:19](Cl)=[O:20])[CH2:16][CH2:15][CH2:14][CH2:13]1>>[Br:1][C:2]1[C:3]([NH:11][C:19](=[O:20])[CH2:18][CH2:17][CH:12]2[CH2:16][CH2:15][CH2:14][CH2:13]2)=[N:4][N:5]2[CH:10]=[CH:9][CH:8]=[N:7][C:6]=12Participants
3
Procedure
The product from Example 110A and 3-cyclopentylpropionyl chloride were processed using the method analogous to that described in Example 1D to provide the title compound. MS (APCI) m/z 337/339 (M+H)+.
Sources & evidence
- ORD record
- ord-61edab5942774a9d8b5c8e724eb2ee4f
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08609669B2
Reaction notes
Loading…